SCHEMBL28116855

SCHEMBL28116855

NNC(=O)N(N)c1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
MAPT P10636 5/20 0.48
KDM4E B2RXH2 4/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 1/20 0.48
ALOX15 P16050 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 3/20 0.40
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28180042 0.82 CYP3A4 (0.47) ALDH1A1MAPTKDM4ELMNAALOX15
SCHEMBL9037566 0.80 ALDH1A1 (0.39) ALDH1A1MAPTTSHRCES2CES1
SCHEMBL21767229 0.80 OGG1 (0.48) MAPTKDM4ELMNANPC1RAB9A
SCHEMBL28177790 0.80 KDM4E (0.44) ALDH1A1MAPTKDM4ELMNARAB9A
SCHEMBL6206534 0.79 NPSR1 (0.48) ALDH1A1L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL27842747 0.78 TSHR (0.46) ALDH1A1MAPTALOX15NPC1SMN1; SMN2
SCHEMBL4385002 0.78 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EL3MBTL1LMNA
SCHEMBL22251861 0.77 IDO1 (0.43) ALDH1A1MAPTKDM4ELMNARAB9A
SCHEMBL27467210 0.77 ALDH1A1 (0.45) ALDH1A1MAPTKDM4EL3MBTL1NPC1
SCHEMBL27892920 0.77 NPC1 (0.40) ALDH1A1MAPTLMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106232581-A Non-platinum based anti-cancer compounds for targeted chemotherapy 卢庆彬 2016-12-14 CN disclosed